• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Why AMC Entertainment Holdings Shares Are Trading Lower By 25%; Here Are 20 Stocks Moving Premarket

    4/4/23 8:04:58 AM ET
    $ADXN
    $AMC
    $BFLY
    $CDAK
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Movies/Entertainment
    Consumer Discretionary
    Get the next $ADXN alert in real time by email

    Gainers

    • AMC Entertainment Hldg Pref Equity Units (NYSE:APE) gained 28.4% to $1.90 in pre-market trading. AMC Entertainment Holdings stated it agreed to settle litigation and move forward with converting its preferred stock into common shares.
    • Butterfly Network, Inc. (NASDAQ:BFLY) jumped 26.2% to $2.36 in pre-market trading after the company received 510(k) clearance for AI-Enable Auto B-Line Counter.
    • Addex Therapeutics Ltd (NASDAQ:ADXN) gained 15.7% to $1.15 in pre-market trading. Addex published dipraglurant data showing in vivo efficacy on motor and non-motor symptoms of Parkinson's disease.
    • Meta Materials Inc. (NASDAQ:MMAT) shares climbed 13.2% to $0.5565 in pre-market trading after jumping 20% on Monday. Meta Materials recently signed a joint development agreement for NPORE battery separator materials with a confidential global Top 10 battery OEM.
    • Clever Leaves Holdings Inc (NASDAQ:CLVR) climbed 12.3% to $0.40 in pre-market trading. The company recently posted upbeat Q4 results.
    • Steakholder Foods Ltd (NASDAQ:STKH) gained 11% to $0.76 in pre-market trading after declining over 3% on Monday.
    • Lipocine Inc (NASDAQ:LPCN) gained 10.4% to $0.35 in pre-market trading. Lipocine said first participant has been dosed in pilot clinical bridge study of LPCN 1154 and approved injectable Brexanolone.
    • Wearable Devices Ltd (NASDAQ:WLDS) surged 9.6% to $0.51 in pre-market trading after dropping more than 10% on Monday. Wearable Devices recently reported 2022 financial results.
    • Comera Life Sciences Holdings Inc (NASDAQ:CMRA) climbed 9% to $0.97 in pre-market trading. Comera Life Sciences announced notice of allowance of US patent application for expansion of core viscosity reduction claims for excipients in SQore platform.
    • PLx Pharma Inc (NASDAQ:PLXP) gained 8.8% to $0.13 in pre-market trading after dropping around 4% on Monday.

    Losers

    • Oncternal Therapeutics, Inc. (NASDAQ:ONCT) fell 57.1% to $0.3390 in pre-market trading after the company disclosed strategic reprioritization and capital preservation. The Zilovertamab Phase 3 study ZILO-301 and Phase 1/2 study CIRM-0001 will be closed based on dynamically changing therapeutic landscape.
    • AMC Entertainment Holdings, Inc. (NYSE:AMC) fell 25% to $3.83 in pre-market trading. AMC Entertainment agreed to settle litigation and move forward with converting its preferred stock into common shares.
    • Remark Holdings Inc (NASDAQ:MARK) shares dropped 16.2% to $1.24 in pre-market trading after the company filed non-timely 10-K with the SEC. The company said it expects revenue for the year ended Dec. 31, 2022 to be significantly less year over year.
    • Codiak BioSciences, Inc. (NASDAQ:CDAK) fell 14.2% to $0.1110 in pre-market trading after dipping over 25% on Monday. Codiak BioSciences recently voluntarily filed for protection under Chapter 11 bankruptcy.
    • ReTo Eco-Solutions Inc (NASDAQ:RETO) fell 11% to $0.32 in pre-market trading after dropping around 8% on Monday. ReTo Eco-Solutions subsidiary recently received overseas order for fully automated block production lines.
    • Harbor Custom Development Inc (NASDAQ:HCDI) fell 8.7% to $5.47 in pre-market after jumping 38% on Monday. Harbor Custom Development recently reported worse-than-expected Q4 sales results.
    • T Stamp Inc (NASDAQ:IDAI) fell 8.3% to $2.75 in pre-market trading. T Stamp filed for mixed-securities shelf offering of up to $50 million.
    • Terran Orbital Corporation (NYSE:LLAP) shares fell 7.5% to $1.72 in pre-market trading.
    • Kazia Therapeutics Ltd (NASDAQ:KZIA) fell 6.8% to $0.96 in pre-market trading.
    • Alaunos Therapeutics Inc (NASDAQ:TCRT) shares fell 5.7% to $0.59 in pre-market trading.

    Now Read This: Top 4 Materials Stocks That Set To Fly In April

    Get the next $ADXN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ADXN
    $AMC
    $BFLY
    $CDAK

    CompanyDatePrice TargetRatingAnalyst
    AMC Entertainment Holdings Inc.
    $AMC
    5/16/2025$3.00Neutral
    B. Riley Securities
    Butterfly Network Inc.
    $BFLY
    3/17/2025Outperform
    William Blair
    Kazia Therapeutics Limited
    $KZIA
    2/6/2025$3.00Buy
    Maxim Group
    AMC Entertainment Holdings Inc.
    $AMC
    2/4/2025$4.00 → $3.25Sell → Neutral
    ROTH MKM
    Butterfly Network Inc.
    $BFLY
    9/10/2024$3.00Buy
    Lake Street
    Terran Orbital Corporation
    $LLAP
    8/19/2024$3.00 → $0.25Buy → Neutral
    H.C. Wainwright
    Addex Therapeutics Ltd
    $ADXN
    7/31/2024$30.00Neutral → Buy
    H.C. Wainwright
    AMC Entertainment Holdings Inc.
    $AMC
    2/29/2024$12.00 → $8.00Neutral
    B. Riley Securities
    More analyst ratings

    $ADXN
    $AMC
    $BFLY
    $CDAK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • B. Riley Securities resumed coverage on AMC Entertainment with a new price target

      B. Riley Securities resumed coverage of AMC Entertainment with a rating of Neutral and set a new price target of $3.00

      5/16/25 8:17:11 AM ET
      $AMC
      Movies/Entertainment
      Consumer Discretionary
    • William Blair initiated coverage on Butterfly Network

      William Blair initiated coverage of Butterfly Network with a rating of Outperform

      3/17/25 7:23:53 AM ET
      $BFLY
      Medical Electronics
      Health Care
    • Maxim Group initiated coverage on Kazia Therapeutics with a new price target

      Maxim Group initiated coverage of Kazia Therapeutics with a rating of Buy and set a new price target of $3.00

      2/6/25 7:53:38 AM ET
      $KZIA
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $ADXN
    $AMC
    $BFLY
    $CDAK
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Large owner Dqi Holdings Inc. bought $300,000 worth of shares (1,363,636 units at $0.22), increasing direct ownership by 30% to 5,961,337 units (SEC Form 4)

      4 - T Stamp Inc (0001718939) (Issuer)

      11/4/24 2:08:54 PM ET
      $IDAI
      Computer Software: Prepackaged Software
      Technology
    • Large owner Lockheed Martin Corp bought 1,000 shares (SEC Form 4)

      4 - Terran Orbital Corp (0001835512) (Issuer)

      11/1/24 5:49:28 PM ET
      $LLAP
      Military/Government/Technical
      Industrials
    • Director Robbins Larry bought $262,251 worth of shares (244,774 units at $1.07) (SEC Form 4)

      4 - Butterfly Network, Inc. (0001804176) (Issuer)

      9/4/24 4:34:48 PM ET
      $BFLY
      Medical Electronics
      Health Care

    $ADXN
    $AMC
    $BFLY
    $CDAK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by ReTo Eco-Solutions Inc.

      SC 13G/A - ReTo Eco-Solutions, Inc. (0001687277) (Subject)

      12/3/24 8:32:02 AM ET
      $RETO
      Industrial Machinery/Components
      Industrials
    • Amendment: SEC Form SC 13G/A filed by ReTo Eco-Solutions Inc.

      SC 13G/A - ReTo Eco-Solutions, Inc. (0001687277) (Subject)

      12/3/24 8:31:02 AM ET
      $RETO
      Industrial Machinery/Components
      Industrials
    • Amendment: SEC Form SC 13G/A filed by ReTo Eco-Solutions Inc.

      SC 13G/A - ReTo Eco-Solutions, Inc. (0001687277) (Subject)

      12/3/24 8:30:28 AM ET
      $RETO
      Industrial Machinery/Components
      Industrials

    $ADXN
    $AMC
    $BFLY
    $CDAK
    SEC Filings

    See more
    • SEC Form 424B3 filed by Kazia Therapeutics Limited

      424B3 - KAZIA THERAPEUTICS LTD (0001075880) (Filer)

      6/11/25 4:32:36 PM ET
      $KZIA
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 424B3 filed by Kazia Therapeutics Limited

      424B3 - KAZIA THERAPEUTICS LTD (0001075880) (Filer)

      6/11/25 4:31:34 PM ET
      $KZIA
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 424B3 filed by Kazia Therapeutics Limited

      424B3 - KAZIA THERAPEUTICS LTD (0001075880) (Filer)

      6/11/25 4:30:25 PM ET
      $KZIA
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $ADXN
    $AMC
    $BFLY
    $CDAK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Director Ono Richard Dana

      4 - Lipocine Inc. (0001535955) (Issuer)

      6/5/25 4:07:01 PM ET
      $LPCN
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 4 filed by Director Jene Jill M.

      4 - Lipocine Inc. (0001535955) (Issuer)

      6/5/25 4:06:49 PM ET
      $LPCN
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 4 filed by Director Papapetropoulos Spyros

      4 - Lipocine Inc. (0001535955) (Issuer)

      6/5/25 4:06:40 PM ET
      $LPCN
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $ADXN
    $AMC
    $BFLY
    $CDAK
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    See more
    • FDA Approval for TESTOSTERONE UNDECANOATE issued to LIPOCINE INC

      Submission status for LIPOCINE INC's drug TESTOSTERONE UNDECANOATE (ORIG-1) with active ingredient TESTOSTERONE UNDECANOATE has changed to 'Approval' on 03/28/2022. Application Category: NDA, Application Number: 208088, Application Classification: Type 3 - New Dosage Form

      3/29/22 4:34:43 AM ET
      $LPCN
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • FDA Tentative Approval for TESTOSTERONE UNDECANOATE

      Submission status for LIPOCINE INC's drug TESTOSTERONE UNDECANOATE (ORIG-1) with active ingredient TESTOSTERONE UNDECANOATE has changed to 'Tentative Approval' on 12/08/2020. Application Category: NDA, Application Number: 208088, Application Classification: Type 3 - New Dosage Form

      12/20/20 4:30:41 PM ET
      $LPCN
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $ADXN
    $AMC
    $BFLY
    $CDAK
    Press Releases

    Fastest customizable press release news feed in the world

    See more

    $ADXN
    $AMC
    $BFLY
    $CDAK
    Leadership Updates

    Live Leadership Updates

    See more

    $ADXN
    $AMC
    $BFLY
    $CDAK
    Financials

    Live finance-specific insights

    See more
    • LAIKA'S ParaNorman Returns to the Big Screen in Remastered RealD 3D for Exclusive Halloween Run Featuring a Brand-New CG Short Film Starring Anna Kendrick and Finn Wolfhard

      Limited engagement includes the world premiere of ParaNorman: The Thrifting Following the record-breaking 2024 re-release of Coraline, LAIKA once again partners with Fathom Entertainment and Trafalgar Releasing to bring this Halloween event to the global moviegoing audience LAIKA's award-winning stop-motion animated film ParaNorman returns this Halloween for a one-week theatrical engagement. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250613109746/en/LAIKA to Re-Release ParaNorman. As with the record-breaking 15th Anniversary 2024 re-release of Coraline in 2D and RealD 3D, LAIKA will bring the gloriously remastered ParaNo

      6/13/25 7:00:00 AM ET
      $AMC
      $CNK
      Movies/Entertainment
      Consumer Discretionary
    • Kazia Therapeutics Announces Transformative Preclinical Data Demonstrating Paxalisib's Potential to Overcome Immunotherapy Resistance in Triple-Negative Breast Cancer (TNBC)

      SYDNEY, June 11, 2025 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ:KZIA), a clinical-stage biotechnology company pioneering next-generation oncology therapeutics, today announced the publication of transformative preclinical research in the journal Molecular Cancer Therapeutics, a journal of the American Association for Cancer Research that underscores the powerful potential of its lead asset, paxalisib, in reshaping the treatment landscape for triple-negative breast cancer (TNBC), one of the most aggressive and treatment-resistant cancer subtypes. The preclinical progra

      6/11/25 8:00:00 AM ET
      $KZIA
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Steakholder Foods Announces Signing of Investment and Convertible Loan Agreements, and Memorandum of Understanding for Proposed Transformative Acquisition of Twine Solutions

      Twine Shareholders Investing into Steakholder at $7 per ADS; More than 200% Premium Above Current ADS Price Strategic Acquisition Would Position Combined Company As Pioneering Force Across Food Tech and Textile Industries, Building Digital Printing and Dyeing Technology Powerhouse Since its foundation, Twine has installed more than 30 systems at leading brands, dye houses and textile fulfillers   Rehovot, Israel, June 11, 2025 (GLOBE NEWSWIRE) -- Steakholder Foods Ltd. (NASDAQ:STKH), a leading innovator in alternative proteins and 3D printing technologies, today announced that it has signed both a non-binding MoU to acquire Twine Solutions Ltd., a transformative force in thread and yar

      6/11/25 8:00:00 AM ET
      $STKH
      Packaged Foods
      Consumer Staples
    • Steakholder Foods Announces Signing of Investment and Convertible Loan Agreements, and Memorandum of Understanding for Proposed Transformative Acquisition of Twine Solutions

      Twine Shareholders Investing into Steakholder at $7 per ADS; More than 200% Premium Above Current ADS Price Strategic Acquisition Would Position Combined Company As Pioneering Force Across Food Tech and Textile Industries, Building Digital Printing and Dyeing Technology Powerhouse Since its foundation, Twine has installed more than 30 systems at leading brands, dye houses and textile fulfillers   Rehovot, Israel, June 11, 2025 (GLOBE NEWSWIRE) -- Steakholder Foods Ltd. (NASDAQ:STKH), a leading innovator in alternative proteins and 3D printing technologies, today announced that it has signed both a non-binding MoU to acquire Twine Solutions Ltd., a transformative force in thread and yar

      6/11/25 8:00:00 AM ET
      $STKH
      Packaged Foods
      Consumer Staples
    • AMC Theatres® to Make Moviegoing More Affordable With a Major Pricing Initiative – Beginning July 9, AMC Stubs Members Will Enjoy a 50% Price Reduction off the Normal Adult Ticket Price All Day Long on Wednesdays

      Beginning Wednesday, July 9, and on Wednesdays thereafter, moviegoers can watch the newest releases on the big screen at 50% off the normal adult-evening ticket price each Wednesday, making movies more affordable and accessible for guests throughout the United States "50% Off Wednesdays" will be available to all AMC Stubs members, which is free to join with an AMC Stubs Insider membership Premium charges for PLF experiences and online ticketing fees still apply, but the base ticket price on those purchases will be 50% off AMC will continue to offer significant discounts on Tuesdays With the spring box office in April and May booming, AMC Theatres® (NYSE:AMC), the largest theatrical exhi

      5/12/25 5:49:00 PM ET
      $AMC
      Movies/Entertainment
      Consumer Discretionary
    • Alpha Cognition Strengthens Its Leadership Team with Appointment of Robert Wills to Board of Directors and Announces Departure of Existing Director John Havens

      Alpha Cognition Inc. (NASDAQ:ACOG) ("Alpha Cognition", or the "Company"), a biopharmaceutical company committed to developing novel therapies for debilitating neurodegenerative disorders, today announced the appointment of Robert Wills, Ph.D., to its Board of Directors, effective immediately April 7, 2025. Dr. Wills brings decades of experience in the pharmaceutical and biotechnology industries, with a distinguished career in drug development, corporate strategy, and executive leadership. "On behalf of the entire Board of Directors, it is a pleasure to welcome Rob, a highly accomplished industry veteran, to our team," said Michael McFadden, Chief Executive Officer of Alpha Cognition, Inc.

      4/10/25 8:30:00 AM ET
      $ACOG
      $CBAY
      $MIST
      $ONCT
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Lipocine Announces Financial Results for the First Quarter Ended March 31, 2025

      SALT LAKE CITY, May 8, 2025 /PRNewswire/ -- Lipocine Inc. (NASDAQ:LPCN), a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery, today announced financial results for the first quarter ended March 31, 2025 and provided a corporate update. Neuroactive Steroids Lipocine has initiated an outpatient Phase 3 safety and efficacy study of LPCN 1154, a non-invasive, rapid onset, oral formulation of brexanolone for the treatment of postpartum depression (PPD). Dosing of the first patient is anticipated in the s

      5/8/25 8:00:00 AM ET
      $LPCN
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • National CineMedia, Inc. Reports Results for Fiscal First Quarter 2025

      Revenue of $34.9 million meets guidance range New long-term agreement with AMC Theaters to further enhance value of NCM advertising platform National CineMedia, Inc. (NASDAQ:NCMI) (the "Company" or "NCM"), the managing member of National CineMedia, LLC (NCM LLC), the operator of the largest cinema advertising platform in the U.S., today announced its consolidated results for the fiscal first quarter ended March 27, 2025. "NCM continues to position itself for future growth, with innovation across our advertising platform, an enhanced long-term partnership with AMC and a dominant position in cinema advertising," said Tom Lesinski, CEO of NCM. "While the first quarter reflected seasonal sof

      5/6/25 4:05:00 PM ET
      $AMC
      $CNK
      $NCMI
      Movies/Entertainment
      Consumer Discretionary
      Advertising
    • Amcor completes combination with Berry Global; Positioned to significantly enhance value for customers and shareholders

      Creates broader more complete portfolio with scale and global breadth, brings together material science and innovation capabilities required to revolutionize product development, enhances positions in attractive categories Provides clear visibility to approximately 12% EPS accretion in FY26 through synergy benefits alone 35%+ EPS accretion by end of FY28 through $650 million total synergies Expected annual cash flow of over $3 billion by FY28 provides significant capacity to fund organic reinvestment, value accretive M&A and capital returns to shareholders through a compelling dividend and share repurchases Unlocks further opportunities to refine portfolio, to enhance average growth rates,

      4/30/25 4:06:00 PM ET
      $AMC
      $AMCR
      Movies/Entertainment
      Consumer Discretionary
      Miscellaneous manufacturing industries